This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $9,313.41 and a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The $10,495.14 firm fixed-price delivery order has a completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,015.42, is a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565047449 pharmaceutical products, specifically RINVOQ ER 15 MG TABLET UU 30S. The $4,470.31 award is a firm fixed-price delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $28,639.87 from the Defense Logistics Agency (DLA). The contract is for the provision of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a performance period through November 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The $5,065.33 Firm Fixed Price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense (DoD). The award is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $32,637.00 and is a firm fixed price delivery order with a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $16,307.64 for the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract is funded by the Defense Logistics Agency, a defense agency, and has an ultimate completion date of May 28, 2025. The contract is a firm fixed price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,522.16 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 45 MG TABLET UU 28S. The contract has an ultimate completion date of February 5, 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $19,587.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S, with a Firm Fixed Price and an ultimate completion date of May 6, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant...